Browsing publications by Dr Lucy Chilton

Newcastle AuthorsTitleYear
Professor Anthony Moorman
Dr Amir Enshaei
Claire Schwab
Dr Lucy Chilton
Alannah Elliott
et al.
A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia2014
Dr Lucy Chilton
Professor Anthony Moorman
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials2014
Dr Ed Schwalbe
Dr Lucy Chilton
Glycerol and acetaminophen as adjuvant therapy did not affect the outcome of bacterial meningitis in Malawian children.2014
Dr Lucy Chilton
Professor Christine Harrison
Professor Anthony Moorman
High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome2014
Dr Lucy Chilton
Professor Christine Harrison
Professor Anthony Moorman
Hyperdiploidy with 49-65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcome.2014
Dr Lucy Chilton
t(6;9)(p22;q34)/DEK-NUP214 rearranged pediatric myeloid leukemia: an international study on 62 patients2014
Professor Christine Harrison
Professor Anthony Moorman
Claire Schwab
Dr Lucy Chilton
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome2013
Dr Lucy Chilton
Professor Anthony Moorman
Distinct patterns of gained chromosomes in high hyperdiploid acute lymphoblastic leukemia with t(1;19)(q23;p13), t(9;22)(q34;q22) or MLL rearrangements2013
Claire Schwab
Dr Lucy Chilton
Heather Morrison
Lisa Jones
Dr Halima Al-shehhi
et al.
Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features2013
Professor Anthony Moorman
Dr Lucy Chilton
Dr Amir Enshaei
Professor Christine Harrison
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated on UKALLXII/ECOG29932013
123